OR WAIT null SECS
November 02, 2008
Policymakers weigh new rules to ensure the safety and quality of drugs made with tiny particles.
October 02, 2008
Manufacturers seek real-world benefits from investment in QbD and risk-management strategies. This article contains bonus online-exclusive material.
September 02, 2008
FDA is taking several measures to ensure that imported drugs meet manufacturing standards.
August 02, 2008
FDA is modernizing adverse-event reporting as part of a revolution in drug-safety assessment.
July 02, 2008
New scientific discoveries promise to expand treatments for rare and neglected diseases.
June 02, 2008
Comparative-effectiveness analysis aims to promote appropriate pharmaceutical spending.
May 02, 2008
Regulators face demands to improve postmarket surveillance and meet review deadlines.
April 02, 2008
Heparin contamination casts a shadow on regulatory oversight of product quality.
March 02, 2008
Quality-by-design submissions may reduce supplements and improve change management.
February 02, 2008
The rise in overseas manufacturing undermines FDA oversight of drug quality.